Endocrine abnormalities and outcome of ischaemic stroke.
Multiple endocrine abnormalities have been reported in stroke patients. In the past few years, it has been claimed that some of these abnormalities may play a role in worsening the neurological deficit and the outcome of stroke. Several mechanisms have been hypothesised, including a direct effect on the development of neuronal cell death, vasospasm, and development of brain edema. In this brief review, we discuss the current knowledge concerning the role of endothelin-1, arginine vasopressin, and cortisol in the pathogenesis of stroke. Finally, we discuss the possibility that leptin, the OB gene product, may be the link of some of these endocrine abnormalities, and that its abnormal secretion during stroke may contribute to the eating disorders and poor nutritional status often seen in these patients.
Franceschini
R
R
Department of Internal Medicine, University of Genoa, Italy. franrob@unige.it
Tenconi
G L
GL
Zoppoli
F
F
Barreca
T
T
D001127:Arginine Vasopressin / Q000502:physiology; D002545:Brain Ischemia / Q000150:complications / Q000503:physiopathology*; D004700:Endocrine System Diseases / Q000150:complications*; D019332:Endothelin-1 / Q000502:physiology; D006801:Humans; D006854:Hydrocortisone / Q000502:physiology; D007031:Hypothalamus / Q000502:physiology; D020738:Leptin / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000502:physiology; D020521:Stroke / Q000150:complications / Q000503:physiopathology*
D019332:Endothelin-1; D020738:Leptin; D001127:Arginine Vasopressin; D006854:Hydrocortisone